Concourse Financial Group Securities’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10626 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10255 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9904 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9679 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9453 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9216 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8997 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8653 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8662 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8478 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8324 |
|
|
2022
Q1 | – | Sell |
-19
| Closed | -$1K | – | 8136 |
|
|
2021
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 2342 |
|
|
2021
Q3 | $1K | Sell |
19
-5
| -21% | -$263 | ﹤0.01% | 2371 |
|
|
2021
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 2330 |
|
|
2021
Q1 | $1K | Buy |
24
+6
| +33% | +$250 | ﹤0.01% | 2302 |
|
|
2020
Q4 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 2250 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6457 |
|
|
2020
Q2 | – | Sell |
-40
| Closed | -$2K | – | 6299 |
|
|
2020
Q1 | $2K | Hold |
40
| – | – | ﹤0.01% | 1953 |
|
|
2019
Q4 | $2K | Hold |
40
| – | – | ﹤0.01% | 1945 |
|
|
2019
Q3 | $2K | Hold |
40
| – | – | ﹤0.01% | 1591 |
|
|
2019
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 2048 |
|
|
2019
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 2079 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5764 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5608 |
|